Saturday 17 October 2026 Export LGND’s income statement to Excel — free account

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $268.1 million, up 60.4% from fiscal 2024. In the quarter to June 2026, revenue grew 33.7%, EPS grew 868.0% and free cash flow grew 35.5%, each against the same quarter a year earlier.

295.54 2.96 −0.99%

Follow LGND

Alert me

Market cap: $6.0B
P/E: 29.5×
Fwd P/E: 54.7×
Dividend yield: —
F-score: 6/9
Altman Z: 5.45
Beneish M: −4.02
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	74.12	30.01	25.47	31.58
P/S ratio Full definition →		13.80	13.64	14.46	21.83
P/FCF ratio Full definition →		136.42	60.02	29.50	44.23
P/Operating CF Full definition →		264.94	79.63	81.53	264.04
P/B ratio Full definition →		3.65	3.59	3.98	6.55
Price to Tangible BV Full definition →		5.64	5.30	5.85	9.66
EV/Sales Full definition →		13.19	12.77	13.49	21.25
EV/EBITDA Full definition →		67.56	48.15	29.82	49.70
EV/Operating CF Full definition →		103.82	69.35	29.98	46.88
EV/FCF Full definition →		130.34	56.19	27.50	43.07
Quick Ratio Full definition →		24.07	21.83	20.81	30.83
Current Ratio Full definition →		24.69	22.23	21.28	31.18
Net Debt/EBITDA Full definition →		(3.71)	(15.05)	(13.85)	(14.86)
Debt/Assets Full definition →		30.17%	28.59%	29.17%	51.54%
Debt/Equity Full definition →		0.47	0.44	0.45	1.16
Asset Turnover Full definition →		0.21	0.21	0.23	0.19
Operating CF/Net income Full definition →		0.11	1.03	(3.65)	0.50
Capex/Depreciation Full definition →		0.13	0.03	0.90	(0.02)
Interest Coverage Full definition →		60.36	7.76	9.94	4.91
Research and Development Expense of Revenue Full definition →		18.20%	5.88%	4.15%	23.03%
Selling, General and Administrative Expense of Revenue Full definition →		24.64%	41.95%	40.28%	45.72%
Intangible Assets out of Total Assets Full definition →		0.23	0.21	0.21	0.14
Share Based Compensation of Revenue Full definition →		12.77%	23.92%	20.49%	21.44%
Graham Net Nets Full definition →		0.07	0.08	0.08	0.04
Graham Number Full definition →		51.09	86.35	94.06	104.22
Earnings Yield Full definition →		1.35%	3.33%	3.93%	3.17%
Free Cash Flow Yield Full definition →		0.73%	1.67%	3.39%	2.26%
Revenue per Share Full definition →		5.90	3.09	2.60	3.17
Operating CF per Share Full definition →		0.67	2.37	2.45	1.20
Capex per Share Full definition →		0.05	0.01	0.34	(0.01)
Free Cash Flow per Share Full definition →		0.72	2.38	2.79	1.19
Cash per Share Full definition →		34.58	39.11	39.81	68.32
Shareholders Equity per Share Full definition →		48.53	52.60	50.16	48.22
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		48.53	52.60	50.16	48.22
Free Cash Flow Full definition →		14.08	46.12	55.44	23.87
Working Capital Full definition →		723.38	794.82	824.75	1,410.38
Capital Expenditures Full definition →		0.99	0.20	6.75	(0.14)
Net Current Asset Value Full definition →		227.32	288.85	330.63	238.76
EV/EBIT Full definition →		189.10	83.48	39.14	65.18
Capex to Sales Full definition →		(0.01)	0.00	(0.13)	0.00
Price to Operating Income Full definition →		197.93	89.17	41.97	66.94
Other line items
Average Receivables Full definition →		50.11	51.75	48.81	61.16
Average Payables Full definition →		4.19	4.24	5.32	8.99
Average Inventory Full definition →		14.32	11.62	13.94	12.88
Average Assets Full definition →		1,215.82	1,251.21	1,218.77	1,567.24
Average Common Equity Full definition →		895.67	923.83	896.43	898.02

Show all line items

Columns are period end dates

Stockrow Weekly